Vitiligo is a skin condition caused by the loss of pigment, or melanin, in certain areas, resulting in white or lighter patches that contrast with the person’s natural skin tone.

Regardless of dose used, povorcitinib use for 24 weeks among patients with extensive nonsegmental vitiligo improved total and facial repigmentation.